Key facts
- It has raised $10.0M across 1 recorded rounds; the latest was Early Stage VC ($10.0M) in Dec 2025.
- Notable investors include Arthur Ventures.
- TJM labs has filed 1 Form D with the SEC, most recently Feb 2026 ($10.0M sold to 2 investors).
- Status: Privately Held (backing).
Investors
1- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for TJM labs
Funding rounds
1 roundsAbout TJM labs
Developer of AI automation tools designed for pharmacy administrative workflows and streamlining tasks. The company's suite of AI-driven tools includes prescription processing, patient assistance (inbound and outbound), benefit investigations, reporting, legacy system integration, and more, enabling community and retail pharmacies to reduce manual work and improve accuracy across care delivery.
- Sector
- Healthcare
- HQ
- Wilmington, DE, United States
- Employees
- 43
- Website
- tjmlabs.com/
- Ownership
- Privately Held (backing)
TJM labs doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in TJM labs shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on TJM labs in its N-PORT filings yet. We sweep new filings monthly.